As per the agreement, JS Link will take on the role of consulting, building, and transferring advanced technology, as well as providing state-of-the-art equipment for Gene Viet Molecular Biology Joint Stock Company’s Gene Testing Center. Expected to be operational in Q2 2026, the center will become a leading gene testing facility in Asia and among the top in the world for DNA testing, combining modern analysis technologies with AI applications and Big Data on human genes.
With a testing capacity of up to 500,000 samples per year, the center will be a pioneer in personalized medicine, proactive disease prevention, and treatment, as well as stem cell applications in healthcare and aesthetics.
“Our collaboration with JS Link brings not only the most advanced technologies in genomics but also marks a significant turning point in putting Vietnam on the map for biotechnology research and applications in the region and worldwide,” emphasized Le Van Khoa, CEO of Gene Viet Molecular Biology Joint Stock Company.
Mr. Lee Jun Young, CEO of JS Link (South Korea), and Mr. Le Van Khoa, CEO of Gene Viet Molecular Biology Joint Stock Company (right)
This collaboration also aligns with the strategic direction of transitioning from manufacturing cooperation to technology transfer, research, and development in biotechnology, as highlighted during General Secretary To Lam’s state visit to South Korea from August 10 to 13, 2025.
About JS Link (South Korea)
Established in 2000, JS Link is a pioneer in biotechnology and genomics with over 20 years of experience. The company has comprehensive capabilities in genomics, proteomics, multi-omics, big biological data, and precision medicine. They have collaborated with numerous hospitals, government agencies, and global corporations.
JS Link is currently a strategic partner in several national gene projects in South Korea and leads initiatives in precision medicine based on gene data. With a team of over 70 experts, including 10 PhD holders, JS Link is recognized as a global leader in the industry.
About Gene Viet Molecular Biology Joint Stock Company
Gene Viet is a vanguard in Vietnam for DNA testing, whole human genome sequencing, pre-implantation genetic screening (PGS), cancer screening, and targeted therapy. The company owns an international-standard ISO 9001-certified testing laboratory, utilizing next-generation sequencing (NGS) technology from top global brands like Thermo Fisher and MGI.
With an impressive accuracy rate of 99.9%, Gene Viet has successfully performed thousands of complex tests recognized internationally.
– Paternity DNA Testing
– Whole Human Genome Sequencing (Genomics)
– Cancer Screening and Targeted Therapy
– Pre-implantation Genetic Screening (PGS)
The Capital Conundrum: Unlocking the Private Investment Boom of 2025–2030.
The private equity market in Vietnam is witnessing a robust recovery, with transaction values rebounding to 2.3 billion USD in 2024 after a sharp decline from its 2019 peak of 4.8 billion USD. Industry experts forecast that the period from 2025 to 2030 will present significant opportunities for businesses to access this capital, but stress that heightened emphasis will be placed on financial transparency and robust legal preparation.
Family Festival – Bonding Three Generations of Love with Long Chau
With the attendance of artist Trường Giang’s family and singer Đăng Khôi, alongside 1500 participants, the “Family Festival” event organized by Long Châu in collaboration with VnExpress, transformed into a record-breaking journey of bonding and love by the picturesque My Khe Beach in Danang.
“Vinmec and Ho Chi Minh City National University Join Forces to Enhance Healthcare Quality”
Vinmec Healthcare System and Ho Chi Minh City National University (HCM NIU) have forged a strategic partnership to enhance the nation’s healthcare standards and develop high-quality medical personnel. This collaboration aims to synergize the expertise of both institutions, elevating the level of healthcare services and fostering professional excellence within the medical community in Vietnam.
2.222 Long Châu Pharmacies: A Mission for a Healthier Vietnam
After nearly a decade of unwavering dedication to community health, Long Chau Pharmacy reached a significant milestone in early July 2025. With the opening of its 2,222nd pharmacy, the company solidified its presence across Vietnam, bringing its expert healthcare services to every corner of the nation.
Unveiling Three Landmark Projects: Nghe An’s Tribute to 80 Years of Independence
On the momentous occasion of the 80th anniversary of the National Day of the Socialist Republic of Vietnam (September 2, 1945 – September 2, 2025), Nghe An is set to inaugurate three significant projects.
